In a ZCC arbitration, CRA was retained to provide expert reports and testimony regarding the damages suffered by claimant due to the termination of a co-promotion agreement for the commercialization of a pharmaceutical in Germany. As part of the damages assessment, CRA analyzed the German market for the product and the relative contribution to sales performance by each co-promotion partner.
Damages in Life Sciences Arbitration
In this chapter published in The Guide to Damages in International Arbitration, Gregory Bell, Andrew Tepperman, and Justin Ho provide a brief overview of...